Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Free Cash Flow (2012 - 2026)

Kamada's (KMDA) quarterly Free Cash Flow came in at $20.2 million in Q2 2026, up 101.05% on a YoY basis from $10.0 million in Q2 2025, and up 2858.21% quarter-over-quarter from $682000.0 in Q1 2026.

Analysis

Kamada (KMDA) Free Cash Flow (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Free Cash Flow for 15 consecutive years, with $20.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Free Cash Flow rose 101.05% year-over-year to $20.2 million; the trailing twelve-month figure through Jun 2026 stood at $45.2 million (down 7.08% YoY), and the FY2025 full-year result was $35.3 million, down 39.42% from the prior year.
  • Free Cash Flow climbed to $20.2 million in Q2 2026 per KMDA's latest filing, from $682000.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $24.3 million in Q3 2024 and bottomed at -$1.7 million in Q1 2023.
  • Historically, Free Cash Flow has averaged $8.8 million across 5 years, with a median of $7.9 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow plunged 129.01% in 2023, then jumped 818.38% in 2024.
  • Over 5 years, Free Cash Flow stood at $7.7 million in 2022, then rose by 4.73% to $8.1 million in 2023, then surged by 64.79% to $13.3 million in 2024, then retreated by 22.38% to $10.3 million in 2025, then jumped by 95.1% to $20.2 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $20.2 million, $682000.0, and $10.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 3.49 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 3.43 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.01 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 572.80 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -563.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 292.04 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 408.00 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -268.64 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 20.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.18 Mn
Mar 31, 2026 682,000.00
Dec 31, 2025 10.34 Mn
Sep 30, 2025 14.01 Mn
Jun 30, 2025 10.04 Mn
Mar 31, 2025 955,000.00
Dec 31, 2024 13.32 Mn
Sep 30, 2024 24.34 Mn
Jun 30, 2024 16.97 Mn
Mar 31, 2024 3.70 Mn
Dec 31, 2023 8.08 Mn
Sep 30, 2023 2.65 Mn
Jun 30, 2023 2.85 Mn
Mar 31, 2023 -1.73 Mn
Dec 31, 2022 7.72 Mn
Sep 30, 2022 7.11 Mn
Jun 30, 2022 11.57 Mn
Mar 31, 2022 5.98 Mn
Dec 31, 2021 -4.23 Mn
Sep 30, 2021 -1.15 Mn